Video

Jane Armer on Findings From Her Lymphedema Research

Author(s):

Jane M. Armer, RN, PhD

Jane Armer the director of ALFP on Findings From Her Lymphedema Research

American Lymphedema Framework Project (ALFP) Director Jane M. Armer, RN, PhD, School of Nursing, University of Missouri, Columbia, describes the results from her research showing that 90% of therapists treat patients using the "golden standard" of lymphedema care and that the majority of the time treatment is to the upper extremities in hospital outpatient settings.

Related Videos
Byoung Chol Cho, MD, PhD, professor, internal medicine, Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine
Stephen J. Freedland, MD
Viktor Grünwald, MD, PhD
Aaron Gerds, MD
Christine M. Lovly, MD, PhD, Ingram Associate Professor of Cancer Research, associate professor, medicine (hematology/oncology), Vanderbilt-Ingram Cancer Center
Haeseong Park, MD, MPH
David L. Porter, MD
Timothy Yap, MBBS, PhD, FRCP
Leo I. Gordon, MD, Abby and John Friend Professor of Oncology Research, professor, medicine (hematology and oncology), Feinberg School of Medicine, Robert H. Lurie Cancer Center
Hetty E. Carraway, MD, MBA, staff associate professor, Department of Medicine, School of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University; member, Immune Oncology Program, Case Comprehensive Cancer Center; vice chair, Strategy and Enterprise Development, Taussig Cancer Institute, Division of Hematologic Oncology and Blood Disorders, Cleveland Clinic
Related Content
Here is your guide to important regulatory approvals made by the FDA in May 2024.
May 31st 2024

OncLive’s May Roundup of Key FDA Approvals in Oncology

Kalyan and Mouli Provide Perspective on the Power of Personalized Medicine in HCC
November 18th 2021

Kalyan and Mouli Provide Perspective on the Power of Personalized Medicine in HCC

FDA
May 29th 2024

AFM24 Plus Atezolizumab Wins FDA Fast Track Designation for EGFR Wild-Type NSCLC

Gordan on Growing the Infrastructure for In-House Genomic Testing
October 14th 2021

Gordan on Growing the Infrastructure for In-House Genomic Testing

Janet Abrahm, MD, FACP, FAAHPM, of Dana-Farber Cancer Institute
May 27th 2024

Non-Pharmacologic Therapies for Pain Management in Patients With Cancer: Opportunities and Challenges

Vikram M. Narayan, MD, of Emory University Hospital
May 23rd 2024

Narayan Discusses Bladder Preservation and the Role of Gene Therapies in NMIBC